The efficacy and toxicity of afatinib in advanced EGFR-positive non-small-cell lung cancer patients after failure of first-generation tyrosine kinase inhibitors: a systematic review and meta-analysis

詳細情報 詳細情報について

• CRID

  1360013171715200128

• DOI

  10.21037/jtd.2017.06.08

• ISSN

  20776624

  20721439

• Web Site

  http://jtd.amegroups.com/article/download/14474/11724

• データソース種別

  • Crossref